Chemed (NYSE: CHE) revenue
Chemed reported revenue of $2,530m for fiscal 2025, 4.1% more than in fiscal 2024 ($2,431m). Since fiscal 2016 its revenue has grown by 60.4%, an average growth of 5.4% a year.
Chemed has grown its revenue for 3 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2022, −0.2%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $2,530m | +4.1% | $338.2m | 13.4% |
| 2024 | $2,431m | +7.4% | $366.5m | 15.1% |
| 2023 | $2,264m | +6.1% | $340.6m | 15.0% |
| 2022 | $2,135m | −0.2% | $343.5m | 16.1% |
| 2021 | $2,139m | +2.9% | $343.0m | 16.0% |
| 2020 | $2,080m | +7.3% | $389.7m | 18.7% |
| 2019 | $1,939m | +8.7% | $257.4m | 13.3% |
| 2018 | $1,783m | +7.0% | $243.6m | 13.7% |
| 2017 | $1,667m | +5.7% | $113.0m | 6.8% |
| 2016 | $1,577m | — | $178.7m | 11.3% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Chemed revenue compared with its sector
By revenue for its latest fiscal year, Chemed ranks 101st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Chemed, 4.1%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 99th | BIO-RAD Laboratories | $2,583m | 0.7% |
| 100th | Medpace | $2,530m | 20.0% |
| 101st | Chemed | $2,530m | 4.1% |
| 102nd | Teladoc Health | $2,530m | −1.5% |
| 103rd | Aveanna Healthcare | $2,433m | 20.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Chemed
- How much revenue did Chemed make in fiscal 2025?
- Chemed reported revenue of $2,530m for fiscal 2025, compared with $2,431m in fiscal 2024.
- How much has the revenue of Chemed grown?
- Between fiscal 2016 and fiscal 2025 it went from $1,577m to $2,530m: 60.4% more, an average growth of 5.4% a year.
- What was the best year for revenue at Chemed?
- Of its last 10 fiscal years, fiscal 2025, with $2,530m.
- Where does Chemed rank in its sector by revenue?
- It ranks 101st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Chemed come from?
- From the annual report (Form 10-K) that Chemed files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Chemed files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Chemed: the Chemed page · annual accounts · net income · dividends paid · insider transactions.
Dividend per share of Chemed by fiscal year, with the filing behind every figure: Chemed dividend history.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.